Dr. Nananda Col, MD

NPI: 1104870377
Total Payments
$1.1M
2022 Payments
$415.38
Companies
6
Transactions
43

Payment Breakdown by Category

Consulting$816,280 (76.6%)
Research$243,890 (22.9%)
Travel$3,569 (0.3%)
Education$1,054 (0.1%)
Food & Beverage$584.49 (0.1%)
Other$415.38 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $816,280 20 76.6%
Unspecified $243,890 2 22.9%
Travel and Lodging $3,569 11 0.3%
Education $1,054 2 0.1%
Food and Beverage $584.49 7 0.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $415.38 1 0.0%

Payments by Type

General
$821,903
41 transactions
Research
$243,890
2 transactions

Top Paying Companies

Company Total Records Latest Year
Biogen, Inc. $681,686 19 $0 (2018)
EMD Serono, Inc. $357,936 10 $0 (2022)
Horizon Therapeutics plc $10,369 4 $0 (2019)
Mallinckrodt LLC $7,243 3 $0 (2018)
Indivior Inc. $5,651 4 $0 (2017)
Janssen Scientific Affairs, LLC $2,907 3 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2022 $415.38 1 EMD Serono, Inc. ($415.38)
2021 $105,578 3 EMD Serono, Inc. ($105,578)
2019 $262,311 10 EMD Serono, Inc. ($251,943)
2018 $148,236 8 Biogen, Inc. ($140,768)
2017 $549,252 21 Biogen, Inc. ($540,919)

All Payment Transactions

43 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
06/02/2022 EMD Serono, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $415.38 General
12/10/2021 EMD Serono, Inc. Consulting Fee Cash or cash equivalent $104,524.00 General
10/31/2021 EMD Serono, Inc. Education In-kind items and services $604.17 General
01/11/2021 EMD Serono, Inc. Education In-kind items and services $450.00 General
11/04/2019 EMD Serono, Inc. Cash or cash equivalent $104,524.25 Research
Study: Validation of a Shared Decision-Making Tool, MS-SUPPORT, to Improve Decisions about Disease Modifying Therapies DMT for Multiple Sclerosis
10/18/2019 Horizon Therapeutics plc Consulting Fee Cash or cash equivalent $9,000.00 General
10/18/2019 Horizon Therapeutics plc Travel and Lodging In-kind items and services $1,065.39 General
10/18/2019 Horizon Therapeutics plc Travel and Lodging In-kind items and services $186.67 General
10/18/2019 Horizon Therapeutics plc Food and Beverage In-kind items and services $116.48 General
08/22/2019 EMD Serono, Inc. Cash or cash equivalent $139,365.66 Research
Study: Validation of a Shared Decision-Making Tool, MS-SUPPORT, to Improve Decisions about Disease Modifying Therapies DMT for Multiple Sclerosis
07/17/2019 EMD Serono, Inc. Consulting Fee Cash or cash equivalent $7,360.00 General
07/17/2019 EMD Serono, Inc. Travel and Lodging In-kind items and services $290.89 General
07/17/2019 EMD Serono, Inc. Food and Beverage In-kind items and services $133.14 General
05/28/2019 EMD Serono, Inc. Travel and Lodging In-kind items and services $268.66 General
11/19/2018 Biogen, Inc. Consulting Fee Cash or cash equivalent $25,626.77 General
11/06/2018 Mallinckrodt LLC Consulting Fee Cash or cash equivalent $6,308.00 General
11/06/2018 Mallinckrodt LLC Travel and Lodging Cash or cash equivalent $813.87 General
11/06/2018 Mallinckrodt LLC Food and Beverage Cash or cash equivalent $121.40 General
08/01/2018 Biogen, Inc. Consulting Fee Cash or cash equivalent $66,826.00 General
05/09/2018 Biogen, Inc. Consulting Fee Cash or cash equivalent $22,500.00 General
05/07/2018 Janssen Scientific Affairs, LLC XARELTO (Drug) Consulting Fee Cash or cash equivalent $225.00 General
Category: Cardiovascular & Metabolism
01/24/2018 Biogen, Inc. Consulting Fee Cash or cash equivalent $25,815.00 General
12/13/2017 Indivior Inc. SUBOXONE (Drug) Consulting Fee Cash or cash equivalent $5,280.00 General
Category: OUD
12/13/2017 Indivior Inc. SUBOXONE (Drug) Travel and Lodging Cash or cash equivalent $304.40 General
Category: OUD
12/13/2017 Indivior Inc. SUBOXONE (Drug) Travel and Lodging Cash or cash equivalent $52.92 General
Category: OUD

Research Studies & Clinical Trials

Study Name Company Amount Records
Validation of a Shared Decision-Making Tool, MS-SUPPORT, to Improve Decisions about Disease Modifying Therapies DMT for Multiple Sclerosis EMD Serono, Inc. $243,890 2

About Dr. Nananda Col, MD

Dr. Nananda Col, MD is a Internal Medicine healthcare provider based in Portland, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104870377.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nananda Col, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $415.38 received in 2022. These payments were reported across 43 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($816,280).

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Internal Medicine
  • Location Portland, ME
  • Active Since 05/20/2006
  • Last Updated 10/20/2009
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1104870377

Products in Payments

  • SUBOXONE (Drug) $5,651
  • XARELTO (Drug) $2,907

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Portland